Matches in Wikidata for { <http://www.wikidata.org/entity/Q43127278> ?p ?o ?g. }
- Q43127278 description "2010 nî lūn-bûn" @default.
- Q43127278 description "2010年の論文" @default.
- Q43127278 description "2010年学术文章" @default.
- Q43127278 description "2010年学术文章" @default.
- Q43127278 description "2010年学术文章" @default.
- Q43127278 description "2010年学术文章" @default.
- Q43127278 description "2010年学术文章" @default.
- Q43127278 description "2010年学术文章" @default.
- Q43127278 description "2010年學術文章" @default.
- Q43127278 description "2010年學術文章" @default.
- Q43127278 description "2010年學術文章" @default.
- Q43127278 description "2010年學術文章" @default.
- Q43127278 description "2010年學術文章" @default.
- Q43127278 description "2010년 논문" @default.
- Q43127278 description "article científic" @default.
- Q43127278 description "article scientific" @default.
- Q43127278 description "article scientifique" @default.
- Q43127278 description "articol științific" @default.
- Q43127278 description "articolo scientifico" @default.
- Q43127278 description "artigo científico" @default.
- Q43127278 description "artigo científico" @default.
- Q43127278 description "artigo científico" @default.
- Q43127278 description "artikel ilmiah" @default.
- Q43127278 description "artikull shkencor" @default.
- Q43127278 description "artikulong pang-agham" @default.
- Q43127278 description "artykuł naukowy" @default.
- Q43127278 description "artículo científico publicado en 2010" @default.
- Q43127278 description "artículu científicu espublizáu en 2010" @default.
- Q43127278 description "bilimsel makale" @default.
- Q43127278 description "bài báo khoa học" @default.
- Q43127278 description "naučni članak" @default.
- Q43127278 description "scienca artikolo" @default.
- Q43127278 description "scientific article published on 16 March 2010" @default.
- Q43127278 description "scientific article published on 16 March 2010" @default.
- Q43127278 description "scientific article published on 16 March 2010" @default.
- Q43127278 description "teaduslik artikkel" @default.
- Q43127278 description "tieteellinen artikkeli" @default.
- Q43127278 description "tudományos cikk" @default.
- Q43127278 description "vedecký článok" @default.
- Q43127278 description "vetenskaplig artikel" @default.
- Q43127278 description "videnskabelig artikel" @default.
- Q43127278 description "vitenskapelig artikkel" @default.
- Q43127278 description "vitskapeleg artikkel" @default.
- Q43127278 description "vědecký článek" @default.
- Q43127278 description "wetenschappelijk artikel" @default.
- Q43127278 description "wissenschaftlicher Artikel" @default.
- Q43127278 description "επιστημονικό άρθρο" @default.
- Q43127278 description "мақолаи илмӣ" @default.
- Q43127278 description "наукова стаття, опублікована в березні 2010" @default.
- Q43127278 description "научна статия" @default.
- Q43127278 description "научная статья" @default.
- Q43127278 description "научни чланак" @default.
- Q43127278 description "научни чланак" @default.
- Q43127278 description "מאמר מדעי" @default.
- Q43127278 description "مقالة علمية نشرت في 16 مارس 2010" @default.
- Q43127278 description "১৬ মার্চ ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q43127278 description "บทความทางวิทยาศาสตร์" @default.
- Q43127278 description "სამეცნიერო სტატია" @default.
- Q43127278 name "Phase I evaluation of telatinib, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in combination with irinotecan and capecitabine in patients with advanced solid tumors" @default.
- Q43127278 name "Phase I evaluation of telatinib, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in combination with irinotecan and capecitabine in patients with advanced solid tumors" @default.
- Q43127278 type Item @default.
- Q43127278 label "Phase I evaluation of telatinib, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in combination with irinotecan and capecitabine in patients with advanced solid tumors" @default.
- Q43127278 label "Phase I evaluation of telatinib, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in combination with irinotecan and capecitabine in patients with advanced solid tumors" @default.
- Q43127278 prefLabel "Phase I evaluation of telatinib, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in combination with irinotecan and capecitabine in patients with advanced solid tumors" @default.
- Q43127278 prefLabel "Phase I evaluation of telatinib, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in combination with irinotecan and capecitabine in patients with advanced solid tumors" @default.
- Q43127278 P1433 Q43127278-E5225D93-3318-4410-BCDF-6842A40DE436 @default.
- Q43127278 P1476 Q43127278-304B9491-E45C-4FD8-9417-6A3314CF6654 @default.
- Q43127278 P2093 Q43127278-064F9737-A3A9-4A16-88B8-3AA30EFF43E0 @default.
- Q43127278 P2093 Q43127278-1C0F2676-4EC4-409A-9D91-D535D0384081 @default.
- Q43127278 P2093 Q43127278-3514C6A6-9D06-466D-A29B-550DBCCB76F8 @default.
- Q43127278 P2093 Q43127278-5BB8BA9A-EB38-4119-8DBB-B133C25B6A26 @default.
- Q43127278 P2093 Q43127278-ADE108AA-604A-4792-8558-18B5CDECE63A @default.
- Q43127278 P2093 Q43127278-D3A6BBE1-8C17-4BBA-A57E-5F15B8094611 @default.
- Q43127278 P2093 Q43127278-EA7A0435-1F52-4A3F-8A73-E4E6800B2358 @default.
- Q43127278 P2093 Q43127278-F88C9A27-FACA-432D-BBC2-6D5BB97159B9 @default.
- Q43127278 P2093 Q43127278-F912AEF8-A3B3-4997-BC9D-1FCA36646F2B @default.
- Q43127278 P304 Q43127278-833A435E-D576-4B0E-8E9F-F1E0CFE2F730 @default.
- Q43127278 P31 Q43127278-DAF9E0C4-E18B-4A6D-9D14-CFFF2D104889 @default.
- Q43127278 P356 Q43127278-0CA47D50-70C1-4B87-9126-5B6C12E63FF7 @default.
- Q43127278 P407 Q43127278-D5DCBC12-B9F1-4932-8711-B7219F2E58E8 @default.
- Q43127278 P433 Q43127278-584D92B7-A5BA-4C14-9DD3-508E5FC1BBD2 @default.
- Q43127278 P478 Q43127278-5C2754E6-57EB-4BDE-B325-F87F22ED4D5C @default.
- Q43127278 P50 Q43127278-7FD3B132-964C-4368-9EF4-E2A8BEDDBBE3 @default.
- Q43127278 P577 Q43127278-B4375332-6B57-4088-8D9D-957B63F6FD05 @default.
- Q43127278 P5875 Q43127278-6EF7F69E-8A4B-4778-AB23-448AF96EDD9B @default.
- Q43127278 P698 Q43127278-3E295CB2-2DEB-4F51-95DE-47EE8CF81FC5 @default.
- Q43127278 P921 Q43127278-83D9CB1B-2FD1-40C3-B33E-C8B644BCEA2C @default.
- Q43127278 P921 Q43127278-8481F29A-E32B-4DD0-8880-E0BFA42CCA06 @default.
- Q43127278 P921 Q43127278-AAE0C3A6-B247-4389-9D14-46F8BEECF502 @default.
- Q43127278 P356 1078-0432.CCR-09-2436 @default.
- Q43127278 P698 20233884 @default.
- Q43127278 P1433 Q332253 @default.
- Q43127278 P1476 "Phase I evaluation of telatinib, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in combination with irinotecan and capecitabine in patients with advanced solid tumors" @default.
- Q43127278 P2093 "Emile E Voest" @default.
- Q43127278 P2093 "Erich Brendel" @default.
- Q43127278 P2093 "Henk M W Verheul" @default.
- Q43127278 P2093 "Jana van der Sar" @default.
- Q43127278 P2093 "Jeanine M Roodhart" @default.
- Q43127278 P2093 "Marja Mergui-Roelvink" @default.
- Q43127278 P2093 "Marlies H G Langenberg" @default.